·   Log in

Archive for February 8th, 2010

Lupin gets generic amlodipine/benazepril (Lorrel) pills for hypertension in US

Monday, February 8, 2010 14:40

Indian generic firm Lupin has received final approval for its amlodipine/benazepril capsules in US.

This was posted under category: Industry  |  Read Full Story  |  0 Comments
Tagged with: , ,

Allosteric modulator ADX71943 shows promise in osteoarthritis pain: Addex

Monday, February 8, 2010 14:15

A new pain killer code-named ADX71943 by Addex Pharmaceuticals has been shown the potential to treat several conditions including oteo-arthritis pains.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments

Indian firm Troikaa may win US patent for diclofenac injection (Dynapar AQ) technology

Monday, February 8, 2010 14:02

Troikaa Pharmaceuticals is expected get a US patent for new method for delivering the pain killer drug diclofenac through injection, reports said.

This was posted under category: Patents  |  Read Full Story  |  0 Comments
Tagged with: ,

Natalizumab (Tysabri) risk of deadly brain infection higher with more doses in multiple sclerosis, warns US FDA

Monday, February 8, 2010 13:31

Natalizumab (Tysabri) can increases the risk of fatal brain infection progressive multifocal leukoencephalopathy (PML) with the number of doses.

This was posted under category: Consumer, health  |  Read Full Story  |  0 Comments
Tagged with: ,

Stem Cell reprogramming technology iPSC by Fate Therapeutics gets US patent

Monday, February 8, 2010 12:53

A new technology to reprogramme human cells into various cells developed by Fate Therapeutics has been granted patent in US.

This was posted under category: Biotech, Pharma  |  Read Full Story  |  0 Comments